Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 8,260 | 29,053 | 32,713 | 61,280 | 55,286 |
| Cost of Goods | 1,285 | 911 | 1,599 | 13,128 | 8,966 |
| Gross Profit | 6,975 | 28,142 | 31,114 | 48,152 | 46,320 |
| Operating Expenses | 522,328 | 1,032,347 | -4,465,319 | 1,223,598 | 1,398,928 |
| Operating Income | -515,068 | -1,003,294 | 4,497,032 | -1,175,318 | -1,351,642 |
| Interest Expense | 0 | 0 | 0 | 27,968 | 7,041 |
| Other Income | 250,490 | 321,704 | 70,824 | -21,548 | 434,936 |
| Pre-tax Income | -264,578 | -681,590 | 4,567,856 | -1,224,834 | -923,747 |
| Income Tax | 133,329 | 48,174 | 21,503 | 5,190 | 369 |
| Net Income Continuous | -397,907 | -729,764 | 4,546,353 | -1,230,024 | -924,116 |
| Net Income Discontinuous | N/A | 373,030 | -315,147 | 114,561 | N/A |
| Minority Interests | -98,136 | -184,753 | -117,720 | -106,433 | -78,854 |
| Net Income | $-299,771 | $-171,981 | $4,348,926 | $-1,009,030 | $-845,262 |
| EPS Basic Total Ops | -0.43 | -0.24 | 5.55 | -1.42 | -1.26 |
| EPS Basic Continuous Ops | -0.57 | -1.01 | 5.80 | -1.73 | -1.38 |
| EPS Basic Discontinuous Ops | N/A | 0.51 | -0.40 | 0.16 | N/A |
| EPS Diluted Total Ops | -0.54 | -0.24 | 5.23 | -1.42 | -1.26 |
| EPS Diluted Continuous Ops | -0.57 | -1.01 | 5.47 | -1.73 | -1.38 |
| EPS Diluted Discontinuous Ops | N/A | 0.51 | -0.38 | 0.16 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.68 | -1.17 | -1.15 | -1.58 | -1.26 |
| EBITDA(a) | $-511,720 | $-989,223 | $4,519,068 | $-1,156,461 | $-1,345,710 |